Videos

An expert discusses the evolving treatments for renal cell carcinoma (RCC) over the last decade, as well as the future role of immunotherapies for patients with RCC.

An expert discusses the future of immunotherapy in light of new frontline treatments like Keytruda that have been demonstrating positive results for patients with non–muscle invasive bladder cancer.

Immunotherapy can cause some side effects that patients and practitioners should look out for.

Yervoy plus Opdivo is a good combination for many patients with kidney cancer, though some individuals should steer clear of the regimen.

After her daughter was diagnosed, Celia Miltz founded the Friends of ET Research.

Angela Fleischman, M.D., Ph.D., is particularly excited for improvements in treating early-stage disease.

After realizing how little awareness there was about MPNs, one advocate looked to his TV background to help.

Jaden Persaud knows firsthand how a MPN diagnosis can affect a family's life.

Many patients with myelodysplastic syndrome are not receiving early treatment.

Learning more about MDS will lead to better diagnostics and more personalized treatments.

Will the word "cure" be used for patients with chronic lymphocytic leukemia (CLL)?

Katherine Heinowitz said she had the best year of her life after being diagnosed with cancer. But to do that, she had to do something she had never done before.